Micron Technology (MU) is slated to release its quarterly financial results on December 17th. The speaker has consistently maintained a 'buy' rating, noting the stock's substantial appreciation, exceeding 100% in fiscal year 2025, driven by fundamental business enhancements. For fiscal Q4 2025, revenue reached $11.32 billion, representing a significant increase over $9.30 billion in the previous quarter and $7.75 billion from the corresponding period last year. Operating cash flow improved to $5.73 billion, up from $4.61 billion sequentially and $3.41 billion year-over-year, resulting in an impressive operating cash flow to sales ratio above 50%. Gross margin expanded to 44.7% from 35.3%, and operating profit margin rose to 32.3% from 19.6%, benefiting from Micron's high operating leverage. The company is uniquely positioned as the sole U.S.-based memory manufacturer, poised to capitalize on government initiatives supporting domestic production and surging demand from the artificial intelligence sector for DRAM and storage, a trend anticipated to persist for the next 4 to 12 quarters. However, a key risk factor is the company's substantial capital expenditures (CapEx), which stood at $4.93 billion in Q4 2025 and $13.80 billion for the full fiscal year. This high CapEx-to-sales ratio, nearly 50% quarterly and 37% annually, makes investors particularly sensitive to the returns generated from these investments, as evidenced by a recent stock drop in another company following similar CapEx announcements. For fiscal Q1 2026, Micron projects revenue of $12.50 billion and a gross profit margin of 50.5%. Valuation analysis reveals a forward P/E ratio of 13.47 and a price-to-forward operating cash flow of 11.66. A discounted cash flow (DCF) framework suggests an intrinsic value per share of $256.58, indicating the stock is currently slightly undervalued relative to its market price of $241.14. Given the stock's attractive valuation alongside the current hypersensitive investor sentiment regarding CapEx, a prudent investment strategy would involve splitting the allocation, buying half before the earnings release and the remaining half after, to mitigate associated risks.